MedPath

Mefloquine Hydrochloride

Mefloquine Hydrochloride Tablets USP

Approved
Approval ID

7f0bb8c9-16b5-1d26-e053-2991aa0ad438

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 17, 2021

Manufacturers
FDA

NuCare Pharmaceuticals,Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Mefloquine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68071-4702
Application NumberANDA076392
Product Classification
M
Marketing Category
C73584
G
Generic Name
Mefloquine Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 17, 2021
FDA Product Classification

INGREDIENTS (9)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSPOVIDONE (15 MPA.S AT 5%)Inactive
Code: 68401960MK
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLOXAMER 188Inactive
Code: LQA7B6G8JG
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
MEFLOQUINE HYDROCHLORIDEActive
Quantity: 250 mg in 1 1
Code: 5Y9L3636O3
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Mefloquine Hydrochloride - FDA Drug Approval Details